Tandem Diabetes Care

Yahoo Finance • 5 days ago

Tandem Diabetes Care Maps Pharmacy Shift, Targets 65% Gross Margin and 2026 Mobi Tubeless Launch

Tandem Diabetes Care logo Key Points Tandem is shifting supplies into the pharmacy channel, which already helped lift Q4 gross margin to 58% and is expected to drive the company to roughly 60%–65% gross margin sooner than previously plan... Full story

Yahoo Finance • 8 days ago

Micron downgraded, Five Below upgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: William Blair upgraded Five Below(FIVE... Full story

Yahoo Finance • 10 days ago

CONMED cut to Neutral at Piper Sandler on lack of catalysts

[Wall Street New York City] aluxum/E+ via Getty Images Shares of Conmed Corporation (CNMD [https://seekingalpha.com/symbol/CNMD]) fell on Tuesday after Piper Sandler downgraded the stock to Neutral from Overweight, noting a lack of cataly... Full story

Yahoo Finance • 10 days ago

Stock market today: Dow, S&P 500, Nasdaq rise as oil tops $100 again, Fed meeting kicks off

US stocks gained ground on Tuesday as fresh attacks in the Iran war drove oil prices higher amid questions over the US push for allies to help protect shipping in the Strait of Hormuz. The Dow Jones Industrial Average (^DJI) led the way u... Full story

Yahoo Finance • 10 days ago

DraftKings, Eli Lilly downgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Morgan Stanley upgraded Lemonade (LMND... Full story

Yahoo Finance • 14 days ago

Stocks making the biggest moves midday: Adobe, Ulta Beauty, Insulet, Klarna, Once Upon a Farm & more

Check out some of the companies making the biggest moves midday: Adobe — The software giant saw shares tumble more than 5%. CEO Shantanu Narayen said that he would step down from his post after a successor has been named. Narayen will rema... Full story

Yahoo Finance • 30 days ago

Tandem Diabetes Care prices $265M convertible debt offering

Tandem Diabetes Care (TNDM [https://seekingalpha.com/symbol/TNDM]) has priced [https://seekingalpha.com/pr/20412464-tandem-diabetes-care-prices-upsized-private-placement-of-265-million-of-convertible-senior]a private offering of $265M aggr... Full story

Yahoo Finance • last month

Walmart downgraded, Etsy upgraded: Wall Street's top analyst calls

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Barclays upgraded Etsy (ETSY) to Overw... Full story

Yahoo Finance • last month

Tandem Diabetes Care targets 10-11% pump shipment growth in 2026 with PayGo transition

Earnings Call Insights: Tandem Diabetes Care, Inc. (TNDM) Q4 2025 MANAGEMENT VIEW * CEO John Sheridan stated, "2025 was a defining year for Tandem, where we surpassed the milestone of $1 billion in sales while delivering on our mission... Full story

Yahoo Finance • 2 months ago

TNDM Investor News: If You Have Suffered Losses in Tandem Diabetes Care, Inc. (NASDAQ: TNDM), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting fr... Full story

Yahoo Finance • 3 months ago

Here Are Tuesday’s Top Wall Street Analyst Research Calls: Allstate, Chubb Ltd., Eli Lilly, KLA Corp., Lockheed Martin, MongoDB, Roku, and More

Thinkstock Quick Read The rotation trade had another run on Wall Street Monday, as tech stocks led the selling once again. While the move away from the AI/Data center trade has gained some strength, the reality is that with a likely thir... Full story

Yahoo Finance • 3 months ago

Don't Buy Tandem Diabetes Care Until This Big Thing Happens

Key Points Tandem Diabetes Care's top-line growth hasn't been great over the past few years. If it can successfully address challenges detrimental to revenue growth, it may become an attractive stock -- even with red ink on the bottom lin... Full story

Yahoo Finance • 4 months ago

Align Technology, Tandem Diabetes, Integra LifeSciences, Lantheus, and Inspire Medical Systems Shares Skyrocket, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated he sees “room for a fur... Full story

Yahoo Finance • 5 months ago

Tandem Diabetes Care outlines path to $1B sales milestone and gross margin gains in 2025 while expanding pharmacy channel

Earnings Call Insights: Tandem Diabetes Care (TNDM) Q3 2025 MANAGEMENT VIEW * John Sheridan, President and CEO, highlighted "significant strategic milestones and delivered record Q3 sales" and stated, "Our substantial progress is start... Full story

Yahoo Finance • 5 months ago

Tandem Diabetes Care soars after double Q3 beats

[Third Quarter Q3 Profits Stock Trading Chart 3D Background] filo * Tandem Diabetes Care is up ~16% in after-hours trading Thursday after posting beats [https://seekingalpha.com/news/4517898-tandem-diabetes-care-gaap-eps-of-0_31-beats-b... Full story

Yahoo Finance • 5 months ago

t:slim X2™ Insulin Pump Now Available with Abbott’s FreeStyle Libre® 3 Plus Sensor in the United States

The t:slim X2™ Insulin Pump with Abbott’s FreeStyle Libre® 3 Plus Sensor is now available in the United States, beginning global commercial rollout. Tandem Diabetes Care begins global commercial rollout of t:slim X2 pump integration with... Full story

Yahoo Finance • 5 months ago

United States Insulin Pump Market Outlook and Company Analysis Report 2025-2033 Featuring Medtronic, Insulet, Tandem Diabetes Care, Roche, Ypsomed, Microtech Medical

Company Logo The United States Insulin Pump Market is projected to grow from US$ 1.55 billion in 2024 to US$ 2.58 billion in 2033, with a CAGR of 5.84% from 2025-2033. This growth is driven by the rising diabetes prevalence, technological... Full story

Yahoo Finance • 6 months ago

Tandem Diabetes, agilon health, GoodRx, Neogen, and Fortrea Stocks Trade Down, What You Need To Know

What Happened? A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. The president's tone and the suggestion of canceling... Full story

Yahoo Finance • 6 months ago

agilon health, Tandem Diabetes, NeoGenomics, Hims & Hers Health, and Oscar Health Stocks Trade Up, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after news of a new government prescription drug policy and a landmark deal with Pfizer eased investor concerns over stricter pricing regulations. The pharmaceutical and b... Full story

Yahoo Finance • 6 months ago

Securities Fraud Investigation Into Tandem Diabetes Care, Inc. (TNDM) Continues – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

LOS ANGELES, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Tandem Diabetes Care, Inc. (“Tandem” or the “Company”) (NASDAQ: TNDM) in... Full story